- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 20th, 2010
Chris Mooney: As Science and Engineering Indicators 2010 itself admits, seeing how the country fares on science in comparison with other nations isn't the only possible means of judgment. If one's standard is more ambitious—emphasizing, in the latest report's words, "what a technologically advanced society requires (either today or in the future) to compete in the world economy and enable its citizens to better take advantage of science progress in their own lives"—then it is very hard to feel good about the current state of affairs in the United States.
For instance, just 13 percent of the public now claims to follow science and technology news "very closely," and this number has been on a downward trend for the past decade, ending with the current low. So while Americans may profess great admiration for science in the abstract, they hardly feel compelled to pay it much attention.
Similarly, there has been little apparent improvement over time in Americans' basic ability to answer factual questions about science correctly. Moreover, the vast majority of our citizens have scant familiarity with key emerging scientific fields that will dramatically shape the future, such as nanotechnology and biotechnology—and it is important to note that these are the only such fields that the NSF report focuses in on. Ask Americans about other coming scientific technologies or quandaries—say, geoengineering, or synthetic biology—and I imagine the responses would be even more dismal.
|Related News Press|
News and information
UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016
Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016
New Agricultural Research Center Debuts at UCF October 12th, 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Making spintronic neurons sing in unison November 18th, 2016